Bristol-Myers Squibb Company

Bristol-Myers Squibb Companyverified

BMY

Price:

$57.76

Market Cap:

$117.15B

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphi...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1972-06-01

Stock Exchange

NYSE

Ticker

BMY

The Enterprise Value as of December 2024 (TTM) for Bristol-Myers Squibb Company (BMY) is 160.66B

According to Bristol-Myers Squibb Company’s latest financial reports and current stock price. The company's current Enterprise Value is 160.66B. This represents a change of 12.91% compared to the average of 142.29B of the last 4 quarters.

Bristol-Myers Squibb Company (BMY) Historical Enterprise Value (quarterly & annually)

How has BMY Enterprise Value performed in the past?

The mean historical Enterprise Value of Bristol-Myers Squibb Company over the last ten years is 132.08B. The current 160.66B Enterprise Value has changed 12.06% with respect to the historical average. Over the past ten years (40 quarters), BMY's Enterprise Value was at its highest in in the June 2022 quarter at 196.53B. The Enterprise Value was at its lowest in in the June 2019 quarter at 72.18B.

Quarterly (TTM)
Annual

Average

132.08B

Median

127.57B

Minimum

85.32B

Maximum

184.85B

Bristol-Myers Squibb Company (BMY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bristol-Myers Squibb Company Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 69.52%

Maximum Annual Enterprise Value = 184.85B

Minimum Annual Increase = -26.34%

Minimum Annual Enterprise Value = 85.32B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023136.16B-26.34%
2022184.85B8.67%
2021170.10B-4.00%
2020177.19B22.51%
2019144.64B69.52%
201885.32B-17.44%
2017103.35B3.22%
2016100.12B-15.85%
2015118.98B18.89%
2014100.07B8.62%

Bristol-Myers Squibb Company (BMY) Average Enterprise Value

How has BMY Enterprise Value performed in the past?

The current Enterprise Value of Bristol-Myers Squibb Company (BMY) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

163.70B

5-year avg

162.59B

10-year avg

132.08B

Bristol-Myers Squibb Company (BMY) Enterprise Value vs. Peers

How is BMY’s Enterprise Value compared to its peers?

Bristol-Myers Squibb Company’s Enterprise Value is less than AbbVie Inc. (381.55B), less than Merck & Co., Inc. (275.11B), greater than Gilead Sciences, Inc. (135.30B), less than Johnson & Johnson (366.92B), less than Eli Lilly and Company (783.09B), less than Pfizer Inc. (216.86B), less than Amgen Inc. (193.56B), greater than Biogen Inc. (26.67B),

CompanyEnterprise ValueMarket cap
381.55B$317.73B
275.11B$251.57B
135.30B$117.09B
366.92B$351.15B
783.09B$755.34B
216.86B$151.34B
193.56B$142.17B
26.67B$21.72B

Build a custom stock screener for Bristol-Myers Squibb Company (BMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bristol-Myers Squibb Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bristol-Myers Squibb Company (BMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bristol-Myers Squibb Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bristol-Myers Squibb Company's Enterprise Value?

What is the highest Enterprise Value for Bristol-Myers Squibb Company (BMY)?

What is the 3-year average Enterprise Value for Bristol-Myers Squibb Company (BMY)?

What is the 5-year average Enterprise Value for Bristol-Myers Squibb Company (BMY)?

How does the current Enterprise Value for Bristol-Myers Squibb Company (BMY) compare to its historical average?